Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis.
ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis. Leukemia. 2019 05; 33(5):1287-1291.
View in:
PubMed
subject areas
Amino Acid Substitution
Amino Acid Substitution
Disease Progression
Disease Progression
Epistasis, Genetic
Epistasis, Genetic
Gene Expression Regulation
Gene Expression Regulation
Genetic Predisposition to Disease
Genetic Predisposition to Disease
Humans
Humans
Janus Kinase 2
Janus Kinase 2
Mutation
Mutation
Primary Myelofibrosis
Primary Myelofibrosis
Prognosis
Prognosis
Repressor Proteins
Repressor Proteins
authors with profiles
Zhizhuang Joe Zhao